Anticholinergic medications: An additional contributor to cognitive impairment in the heart failure population?

Drugs and Aging

Volumn 31, Issue 10, 2014, Pages 749-754

  Shaukat, Arslan ^a,b   Habib, Amir ^a   Lane, Kathleen A ^a   Shen, Changyu ^a   Khan, Saba ^a   Hellman, Yaron M ^a   Boustani, Malaz ^a   Malik, Adnan S ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; FUROSEMIDE; METOPROLOL;

ADULT; ANEMIA; ANTICHOLINERGIC COGNITIVE BURDEN SCORING SCALE; ANTICHOLINERGIC EFFECT; ARTICLE; CHRONIC KIDNEY DISEASE; COGNITIVE DEFECT; COMORBIDITY; CONGENITAL HEART DISEASE; CONGESTIVE HEART FAILURE; CROSS-SECTIONAL STUDY; DEPRESSION; DIABETES MELLITUS; DIASTOLIC HEART FAILURE; DISEASE ASSOCIATION; DISEASE DURATION; HEART EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; SYSTOLIC HEART FAILURE; AGED; AGING; CHEMICALLY INDUCED; COGNITION DISORDERS; ELDERLY CARE; FEMALE; HEART FAILURE; MALE; MIDDLE AGED; UNITED STATES;

AGED; AGING; CHOLINERGIC ANTAGONISTS; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SERVICES FOR THE AGED; HEART FAILURE; HUMANS; INDIANA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84907799096     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.1007/s40266-014-0204-2     Document Type: Article

References (21)

1. Vogels RL, Scheltens P, Schroeder-Tanka JM, et al. Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail. 2007;9(5):440-9.
2. Heckman GA, Patterson CJ, Demers C, et al. Heart failure and cognitive impairment: challenges and opportunities. Clin Interv Aging. 2007;2(2):209-18.
3. Bauer LC, Johnson JK, Pozehl BJ. Cognition in heart failure: an overview of the concepts and their measures. J Am Acad Nurse Pract. 2011;23(11):577-85.
4. Sauve MJ, Lewis WR, Blankenbiller M, et al. Cognitive impairments in chronic heart failure: a case controlled study. J Card Fail. 2009;15(1):1-10.
5. Gaviria M, Pliskin N, Kney A. Cognitive impairment in patients with advanced heart failure and its implications on decision-making capacity. Congest Heart Fail. 2011;17(4):175-9.
6. Cameron J, Worrall-Carter L, Page K, et al. Does cognitive impairment predict poor self-care in patients with heart failure? Eur J Heart Fail. 2010;12(5):508-15.
7. Foster ER, Cunnane KB, Edwards DF, et al. Executive dysfunction and depressive symptoms associated with reduced participation of people with severe congestive heart failure. Am J Occup Ther. 2011;65(3):306-13.
8. Hoth KF, Poppas A, Moser DJ, et al. Cardiac dysfunction and cognition in older adults with heart failure. Cogn Behav Neurol. 2008;21(2):65-72.
9. Zuccala G, Marzetti E, Cesari M, et al. Correlates of cognitive impairment among patients with heart failure: results of a multicenter survey. Am J Med. 2005;118(5):496-502.
10. Kindermann I, Fischer D, Karbach J, et al. Cognitive function in patients with decompensated heart failure: the Cognitive Impairment in Heart Failure (CogImpair-HF) study. Eur J Heart Fail. 2012;14(4):404-13.
11. Tune L, Carr S, Cooper T, et al. Association of anticholinergic activity of prescribed medications with postoperative delirium. J Neuropsychiatry Clin Neurosci. 1993;5(2):208-10.
12. Antonelli Incalzi R, Trojano L, Acanfora D, et al. Verbal memory impairment in congestive heart failure. J Clin Exp Neuropsychol. 2003;25(1):14-23.
13. Keller S, Frishman WH. Neuropsychiatric effects of cardiovascular drug therapy. Cardiol Rev. 2003;11(2):73-93.
14. Tune LE. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry. 2001;62(Suppl 21):11-4.
15. Campbell N, Boustani M, Limbil T, et al. The cognitive impact of anticholinergics: a clinical review. Clin Interv Aging. 2009;4:225-33.
16. Cancelli I, Gigli GL, Piani A, et al. Drugs with anticholinergic properties as a risk factor for cognitive impairment in elderly people: a population-based study. J Clin Psychopharmacol. 2008;28(6):654-9.
17. Carnahan RM, Lund BC, Perry PJ, et al. The anticholinergic drug scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol. 2006;46(12):1481-6.
18. Uusvaara J, Pitkala KH, Kautiainen H, et al. Association of anticholinergic drugs with hospitalization and mortality among older cardiovascular patients: a prospective study. Drugs Aging. 2011;28(2):131-8.
19. Boustani M, Campbell N, Munger S, et al. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health. 2008;4(3):311-20.
20. Pasina L, Djade CD, Lucca U, et al. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study. Drugs Aging. 2013;30(2):103-12.
21. Carriere I, Fourrier-Reglat A, Dartigues JF, et al. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med. 2009;169(14):1317-24.